#PharmaNews #GLP1 #ObesityTreatment #EliLilly #NovoNordisk #HealthcareTrends #PharmaIndustry To view or add a comment, sign in Nereus Expands Potential Use in GLP-1 Patients Vanda Pharmaceuticals has initiated a Phase 3 trial evaluating Nereus (tradipitant) to prevent nausea and vomiting in patients receiving high-dose GLP-1 therapies
Syncope, which is a brief loss of consciousness or near-fainting episode, combined with palpitations indicates a potential dangerous arrhythmia and requires emergency evaluation
Later, well discuss the side effects, so that you know what to look out for
Glutathione (2400mg 4 vials) and Vitamin C 7500mg
They work by mimicking the effects of a hormone called GLP-1, which helps regulate blood sugar levels and control appetite
Semaglutide works by mimicking glucagon-like peptide-1 (GLP-1), a hormone that regulates appetite and blood sugar